CYTOTOXICITY OF A RECOMBINANT DIPHTHERIA TOXIN-GRANULOCYTE COLONY-STIMULATING FACTOR FUSION PROTEIN ON HUMAN LEUKEMIC BLAST CELLS

Citation
De. Chadwick et al., CYTOTOXICITY OF A RECOMBINANT DIPHTHERIA TOXIN-GRANULOCYTE COLONY-STIMULATING FACTOR FUSION PROTEIN ON HUMAN LEUKEMIC BLAST CELLS, Leukemia & lymphoma, 11(3-4), 1993, pp. 249-262
Citations number
NO
Categorie Soggetti
Hematology
Journal title
ISSN journal
10428194
Volume
11
Issue
3-4
Year of publication
1993
Pages
249 - 262
Database
ISI
SICI code
1042-8194(1993)11:3-4<249:COARDT>2.0.ZU;2-G
Abstract
Granulocyte colony-stimulating factor (G-CSF) is a potent stimulator o f the growth of normal and malignant hematopoietic cells and synergize s with other factors such.as interleukin-3 (IL-3) and granulocyte-macr ophage colony-stimulating factor (GM-CSF). The action of G-CSF is medi ated through a specific membrane receptor, however it is not clear if all of the effects of G-CSF are direct or indirect. As a step towards addressing this problem, a recombinant diphtheria toxin (DT)-related h uman G-CSF fusion protein has been constructed and purified from E. co li. The 70,000 dalton chimeric protein has immunologic determinants ch aracteristic of both DT and G-CSF. At high concentrations, DAB486-G-CS F is cytotoxic towards G-CSF-dependent OCI/AML1 cells, but not factor independent OCI/AML3 cells; colony formation by G-CSF-responsive leuke mic blasts from a patient with acute myeloblastic leukemia (AML) was a lso inhibited. The G-CSF fusion toxin displayed ADP-ribosyltransferase activity in a cell-free system. Genetic conjugation of G-CSF to an en zymatically inactive DT mutant, CRM197, resulted in a 200-fold reducti on in the ability of G-CSF to stimulate normal bone marrow colony form ation. These results suggest that fusion of G-CSF to DT sequences inte rferes with some of the activity but not the specificity of the ligand binding domain of the molecule. Nevertheless, DAB486-G-CSF may be inc luded with the increasing number of other toxin-hormone fusion protein s whose toxicity is directed towards specific receptor-beaning cells, and may represent a novel approach towards the study and treatment of leukemia.